Jun 26, 2025
Biosimilar Approvals in 2025: Key FDA Trends, Interchangeables & Industry Outlook
The 2025 biosimilars landscape marks a pivotal shift in the pharmaceutical industry. With increasing FDA approvals, broader therapeutic applications, and greater affordability, biosimilars are no longer a future trend—they're today’s reality.
From interchangeable biosimilars improving pharmacy-level substitution to U.S. biopharmaceutical companies leading global innovation, the market is evolving fast. Procurement teams, regulatory professionals, and decision-makers must stay informed to adapt quickly.